Today, Inform Diagnostics (MLS), the largest independent anatomical pathology
lab in the United States, reported that they are now adopting a new benchmark
to objectively measure the quality of anatomical pathology services and
diagnostic accuracy. MLS announced that they will begin publishing their
concordance rates with outside academic institutions as an unbiased measure
Each year, thousands of patients request a review from leading academic
institutions, typically as part of their follow-up care, and sometimes
just as a second opinion. In reviewing nearly 3,000 cases over the most
recent trailing 12 months, MLS reported 100% Concordance rates for major
diagnoses, and 99.4% Concordance rates for minor diagnoses. MLS’s
Concordance rates for major and minor diagnoses are obtained from unbiased
third party review by important institutions such as the Cleveland Clinic,
Harvard University, Johns Hopkins, MD Anderson, Mayo Clinic, UCSF and
University of Michigan.
Although published research on this topic is limited, compared to MLS’s
Concordance rates of 99.4%, other lab groups report Concordance rates
of 92.1% to 96.3%*. Therefore, for every 10,000 patients, MLS is reporting
approximately 60 Minor discrepancies
versus published data which indicates other labs are running at 370 to 790 Major
and Minor discrepancies per 10,000 patients, a rate that is 6 to 15 times
that of MLS.
Richard Lash, MD, Chief Medical Officer at the Inform Diagnostics, noted
that he believes the superior concordance rates are “due to a variety
of factors, including subspecialty expertise, consensus-based terminology
and criteria, ongoing educational and research activities, and our unique
Diagnosis-based Analytic Quality Assurance (DAQA) program. This program
involves a statistical review of diagnostic code usage, designed to identify,
analyze and educate in order to minimize areas of interpretive variability.”
*Hahm et al.
Arch Pathol Lab Med 2001;125:736-739. Renshaw & Gould.
Am J Clin Pathol 2005;124:878-882. Weir et al.
About Inform Diagnostics
Serving more than 5,500 patients each day,
Inform Diagnostics is a leader in providing an academic-caliber pathology laboratory with
diagnostic services in the fields of dermatology, gastroenterology, hematology
and urology. Building upon our experience with health IT, we also offer
accessible technology solutions to assist healthcare professionals as
they work towards accordance with Meaningful Use initiatives.
Inform Diagnostics, a wholly owned subsidiary of Japan-based Inform Diagnostics Holdings
Inc., employs a talented team of leading pathologists, histologists, lab
technicians, technology consultants, and other medical professionals —
all driven to help provide the highest and most up-to-date levels of diagnostic
quality, enhanced workflow and practice solutions possible. It’s
part of our commitment: not only to scientific excellence, but to patients